INNOVATORS Gold Award - New Orleans City Business
INNOVATORS Gold Award - New Orleans City Business
INNOVATORS Gold Award - New Orleans City Business
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
MEDICAL<br />
Aquadex FlexFlow<br />
Ochsner Health System<br />
Key innovation: an ultrafiltration process to remove<br />
water and salt from the body at a rate controlled by the<br />
attending physician<br />
Biggest clients: cardiovascular patients<br />
Where they’re based: <strong>New</strong> <strong>Orleans</strong><br />
Top executive: Mark French, vice president of the<br />
Ochsner Heart and Vascular Institute<br />
Year introduced: 2007<br />
PHOTO BY FRANK AYMAMI<br />
PATIENTS WITH CONGESTIVE heart failure often suffer<br />
life-threatening excess fluid retention that doctors formerly<br />
removed with intravenous diuretics. That was until<br />
the invention of the Aquadex FlexFlow Fluid Removal<br />
System in 2002.<br />
The Ochsner Heart and Vascular Institute was the first<br />
to use the system locally and has treated some 20 patients<br />
since employing the device last year. The institute credits<br />
cardiologist Dr. Hector Ventura with leading the push to<br />
offer the procedure here.<br />
“I knew many of the people who were involved in the<br />
(development of the) device,” said Ventura, director of the<br />
institute’s Cardiology Residency Program. “This machine<br />
will help take the fluid away without creating more problems<br />
for the patient.”<br />
Aquadex uses ultrafiltration, a process used in dialysis,<br />
to remove water and salt from the body at a rate controlled<br />
by the attending physician. The device can remove up to a<br />
pound of water and salt per hour without adversely affecting<br />
kidney function, heart rate, blood pressure or the electrolyte<br />
balance, according to Congestive Heart Failure<br />
Solutions, the Minneapolis medical device company that<br />
holds the patent for the Aquadex system.<br />
The system is small and portable, engaged by inserting<br />
catheters into patients’ veins. Aquadex patients achieve a<br />
28 percent greater net fluid loss over standard care, according<br />
to the 2006 results of a medical trial of 200 patients,<br />
and a 63 percent reduction in days rehospitalized for heart<br />
failure over standard care. These results reduce medical<br />
costs to hospitals and improve the quality of life for<br />
patients and their families, CHFS emphasizes.<br />
Susan Reyes, a local CHFS representative, said hospitals<br />
can buy the system for $25,000 per unit and offer treatment<br />
for less than $1,000 per session, accounting for disposal<br />
filters that are $900 each.<br />
While Ochsner was first to use the system in the <strong>New</strong><br />
<strong>Orleans</strong> area, Reyes said the procedure is now available at<br />
Tulane Medical Center and the Louisiana State University<br />
Interim Hospital.<br />
Ventura shared one of his most memorable cases to<br />
date, a lady who was treated with the system for seven<br />
days.<br />
“She lost about 30 pounds of fluid. She was very<br />
grateful.”•<br />
— Diana Chandler<br />
Dr. Hector Ventura, cardiologist and director of Ochsner’s Heart and Vascular Institute, led the push to offer the Aquadex System FlexFlow<br />
to remove water and salt from patients.<br />
<strong>New</strong> <strong>Orleans</strong> <strong>City</strong><strong>Business</strong> 35A